The US Food and Drug Administration has warned the Indian health ministry of a possible introduction of drugs containing harmful steroids which are being marketed as new dietary supplements.
According to the FDA, the drugs are being marketed as body building supplements, protein or vitamin supplements. An overdose of steroids might lead to a number of problems including male infertility, masculinisation of women and stunted growth in children.
The FDA and a number of European countries have already issued a class-I recall on such products though they had been in the market for more than six months before the health agency decided to issue the advisory.
"The products were found to contain steroid or steroid-like substances making them unapproved new drug. Most of these products were distributed through internet rather than through a distributor network", the statement read.